Axon Enterprise, Inc (NASDAQ:AXON) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Axon Enterprise, Inc (NASDAQ:AXON) have received an average rating of “Moderate Buy” from the nineteen research firms that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $712.75.

Several research analysts have recently issued reports on the company. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. Piper Sandler decreased their target price on Axon Enterprise from $690.00 to $674.00 and set an “overweight” rating for the company in a research report on Thursday, May 7th. TD Cowen decreased their target price on Axon Enterprise from $950.00 to $825.00 and set a “buy” rating for the company in a research report on Wednesday, April 8th. Barclays decreased their target price on Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating for the company in a research report on Friday, May 8th. Finally, Weiss Ratings raised Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, May 8th.

Axon Enterprise Trading Down 1.8%

NASDAQ AXON opened at $392.34 on Friday. Axon Enterprise has a fifty-two week low of $339.01 and a fifty-two week high of $885.91. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. The stock has a 50 day simple moving average of $425.17 and a two-hundred day simple moving average of $508.74. The stock has a market cap of $31.62 billion, a P/E ratio of 157.57, a price-to-earnings-growth ratio of 9.39 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.91 million. During the same quarter in the prior year, the company earned $1.47 EPS. The business’s revenue was up 33.7% compared to the same quarter last year. On average, analysts forecast that Axon Enterprise will post 1.41 earnings per share for the current year.

Insider Activity at Axon Enterprise

In related news, Director Jeri Williams sold 157 shares of the firm’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $490.00, for a total transaction of $76,930.00. Following the completion of the transaction, the director owned 1,159 shares of the company’s stock, valued at $567,910. This trade represents a 11.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total value of $5,002,400.00. Following the transaction, the chief executive officer directly owned 3,090,997 shares of the company’s stock, valued at approximately $1,546,240,339.28. This trade represents a 0.32% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 13,855 shares of company stock worth $7,109,828 over the last quarter. 4.20% of the stock is currently owned by company insiders.

Institutional Trading of Axon Enterprise

Institutional investors and hedge funds have recently modified their holdings of the business. Creative Financial Designs Inc. ADV bought a new stake in shares of Axon Enterprise in the 4th quarter worth $28,000. New Millennium Group LLC bought a new stake in shares of Axon Enterprise in the 3rd quarter worth $29,000. Sound Income Strategies LLC increased its holdings in shares of Axon Enterprise by 550.0% in the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after purchasing an additional 44 shares in the last quarter. Camelot Portfolios LLC bought a new stake in shares of Axon Enterprise in the 4th quarter worth $30,000. Finally, Root Financial Partners LLC bought a new stake in shares of Axon Enterprise in the 3rd quarter worth $34,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.